Skip to main content

Sound Advice: July 8, 2026

Why you must read the fine print for drug commercials on TV

You must read the fine print in TV drug commercials because the ad’s main message can sound much simpler than the real risks, limits, and conditions. Prescription drug ads are required to disclose major side effects and other important safety information, and those disclosures can be hard to absorb when they are delivered quickly or in small text.

Why it matters

  • The commercial may highlight benefits while the fine print reveals serious side effects, warnings or people who should not use the drug.
  • The ad can make a medicine sound right for your situation even though only a doctor or pharmacist can tell whether it fits your health history.
  • Some disclosures are there to balance the claims in the ad, so the details matter just as much as the headline.

What to watch for

  • Common and serious side effects.
  • Drug interactions with medicines you already take.
  • Who should avoid the drug, including certain conditions or age groups.
  • Dosing, duration, and whether results vary by patient.

Practical rule

Treat the commercial as a prompt to learn more, not as a recommendation to buy. If a drug ad catches your attention, the safest next step is to check the prescribing information and talk with a healthcare professional before deciding anything.

Here are examples of problematic side effects commonly disclosed in TV drug ads: headache, dry mouth, liver damage, anaphylaxis, drowsiness, suicidal thoughts, blurry vision, rash, constipation, and fatal throat swelling.

Why these matter

Some side effects are merely unpleasant, but others are serious or life-threatening, which is why TV drug commercials are required to disclose risks. The problem is that ads often emphasize benefits while the risk information is fast, dense, and hard to weigh in context.

Examples by severity

  • Mild but bothersome: headache, dry mouth, constipation.
  • Serious: liver damage, blurry vision, rash.
  • Severe or emergency-level: anaphylaxis, suicidal thoughts, fatal throat swelling, dangerous sleep-related impairment.

Important caveat

Not every listed side effect is common, and some are rare but still required to be mentioned because they are severe. The list in a commercial should be treated as a safety warning, not a full medical judgment about whether the drug is right for you.

Showing athletics in the background can be misleading because it suggests a stronger connection, relevance or endorsement than actually exists. In media, background sports imagery can also create hype or implied credibility that distracts from the real message.

Why it misleads

  • It can make unrelated claims seem more trustworthy by borrowing the appeal of sports.
  • It may imply that an athlete, team or performance idea is connected to the product or message when it is not.
  • It can push viewers toward emotional rather than careful judgment, which is a common source of misinformation in sports-related coverage.

Common effect

Athletics imagery often works as a shortcut: people notice the action, energy, and authority, then assume the rest of the message is equally solid. That is why background sports visuals are often used to sell a feeling rather than convey a full explanation.

Practical reading

The safest approach is to separate the visual cue from the actual claim. If the athletic imagery is not directly tied to evidence, terms or performance data, treat it as decoration or persuasion rather than proof.

Comments

Post a Comment

Popular posts from this blog

Sound Advice: January 15, 2025

Why investors shouldn't pay attention to Wall Street forecasts   Investors shouldn't pay attention to Wall Street forecasts for several compelling reasons: Poor accuracy Wall Street forecasts have a terrible track record of accuracy. Studies show that their predictions are often no better than random chance, with accuracy rates as low as 47%   Some prominent analysts even perform worse, with accuracy ratings as low as 35% Consistent overestimation Analysts consistently overestimate earnings growth, predicting 10-12%                 annual growth when the reality is closer to 6%.   This overoptimism can                 lead investors to make overly aggressive bets in the market. Inability to predict unpredictable events The stock market is influenced by numerous unpredictable factors, including geopolitical events, technological changes, and company-specific news.   Anal...
Post a Comment
Read more

Sound Advice: January 3, 2025

2025 Market Forecasts: Stupidity Taken To An Extreme   If you know anything about stock market performance, you can only gag at the nonsense “esteemed forecasters” are now putting forth about the prospective path of stocks in the year ahead.   Our cousins in the UK would call this rubbish.   I would not be as kind. Leading the Ship of Fools is the forecast from the Chief Investment Strategist at Oppenheimer who is looking for a year-end 2025 level for the Standard & Poor’s Index of 7,100, a whopping 21% increase from the most recent standing.   Indeed, most of these folks are looking for double-digit gains.   Only two expect stocks to weaken. In the last 30 years, the market has risen by more than 20% only 15 times.   The exceptional span during that time was 1996-1999, which accounted for four of those jumps.   What followed in 2000 through 2002 was the polar opposite: 2000:      -9.1% 2001:     -11.9% ...
Post a Comment
Read more

Sound Advice: July 16, 2025

Fixed annuities are poor investments Fixed annuities are often criticized as poor investments for several reasons, despite their reputation for providing stable, predictable income.  Here are the key drawbacks and concerns:   High Fees and Commissions Internal Fees:  Fixed annuities can carry a range of fees, including administrative charges, mortality expense risk fees, and rider fees. These can add up to 2%–4% per year, significantly eroding returns over time. Commissions:  Sales agents and financial advisors often receive high commissions for selling annuities—sometimes as much as 5%–8% of the invested amount. This creates a financial incentive for advisers to recommend them, even when they may not be the best fit for the client. Comparison to Other Investments:  Mutual funds and ETFs typically have much lower fees and commissions, making them more cost-effective for long-term growth. Limited Growth a...
Post a Comment
Read more